The design, production, and characterisation of tissue-engineered scaffolds made of polylactic-co-glycolic acid (PLGA), polycaprolactone (PCL) and their blends obtained through electrospinning (ES) or solvent casting/particulate leaching (SC) manufacturing techniques are presented here. The polymer blend composition was chosen to always obtain a prevalence of one of the two polymers, in order to investigate the contribution of the less concentrated polymer on the scaffolds' properties. Physical-chemical characterization of ES scaffolds demonstrated that tailoring of fibre diameter and Young modulus (YM) was possible by controlling PCL concentration in PLGA-based blends, increasing the fibre diameter from 0.6 to 1.0 mu m and reducing the YM from about 22 to 9 MPa. SC scaffolds showed a "bubble-like" topography, caused by the porogen spherical particles, which is responsible for decreasing the contact angles from about 110 degrees in ES scaffolds to about 74 degrees in SC specimens. Nevertheless, due to phase separation within the blend, solvent-casted samples displayed less reproducible properties. Furthermore, ES samples were characterised by 10-fold higher water uptake than SC scaffolds. The scaffolds suitability as iPSCs culturing support was evaluated using XTT assay, and pluripotency and integrin gene expression were investigated using RT-PCR and RT-qPCR. Thanks to their higher wettability and appropriate YM, SC scaffolds seemed to be superior in ensuring high cell viability over 5 days, whereas the ability to maintain iPSCs pluripotency status was found to be similar for ES and SC scaffolds.

Investigation on electrospun and solvent-casted PCL-PLGA blends scaffolds embedded with induced pluripotent stem cells for tissue engineering / Rosalia, Mariella; Giacomini, Martina; Tottoli, Erika Maria; Dorati, Rossella; Bruni, Giovanna; Genta, Ida; Chiesa, Enrica; Pisani, Silvia; Sampaolesi, Maurilio; Conti, Bice. - In: PHARMACEUTICS. - ISSN 1999-4923. - 15:12(2023), pp. 1-22. [10.3390/pharmaceutics15122736]

Investigation on electrospun and solvent-casted PCL-PLGA blends scaffolds embedded with induced pluripotent stem cells for tissue engineering

Sampaolesi, Maurilio
Penultimo
Writing – Review & Editing
;
2023

Abstract

The design, production, and characterisation of tissue-engineered scaffolds made of polylactic-co-glycolic acid (PLGA), polycaprolactone (PCL) and their blends obtained through electrospinning (ES) or solvent casting/particulate leaching (SC) manufacturing techniques are presented here. The polymer blend composition was chosen to always obtain a prevalence of one of the two polymers, in order to investigate the contribution of the less concentrated polymer on the scaffolds' properties. Physical-chemical characterization of ES scaffolds demonstrated that tailoring of fibre diameter and Young modulus (YM) was possible by controlling PCL concentration in PLGA-based blends, increasing the fibre diameter from 0.6 to 1.0 mu m and reducing the YM from about 22 to 9 MPa. SC scaffolds showed a "bubble-like" topography, caused by the porogen spherical particles, which is responsible for decreasing the contact angles from about 110 degrees in ES scaffolds to about 74 degrees in SC specimens. Nevertheless, due to phase separation within the blend, solvent-casted samples displayed less reproducible properties. Furthermore, ES samples were characterised by 10-fold higher water uptake than SC scaffolds. The scaffolds suitability as iPSCs culturing support was evaluated using XTT assay, and pluripotency and integrin gene expression were investigated using RT-PCR and RT-qPCR. Thanks to their higher wettability and appropriate YM, SC scaffolds seemed to be superior in ensuring high cell viability over 5 days, whereas the ability to maintain iPSCs pluripotency status was found to be similar for ES and SC scaffolds.
2023
electrospinning; iPSC; polymer blends; solvent casting/particulate leaching
01 Pubblicazione su rivista::01a Articolo in rivista
Investigation on electrospun and solvent-casted PCL-PLGA blends scaffolds embedded with induced pluripotent stem cells for tissue engineering / Rosalia, Mariella; Giacomini, Martina; Tottoli, Erika Maria; Dorati, Rossella; Bruni, Giovanna; Genta, Ida; Chiesa, Enrica; Pisani, Silvia; Sampaolesi, Maurilio; Conti, Bice. - In: PHARMACEUTICS. - ISSN 1999-4923. - 15:12(2023), pp. 1-22. [10.3390/pharmaceutics15122736]
File allegati a questo prodotto
File Dimensione Formato  
Rosalia_Investigation_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 3.02 MB
Formato Adobe PDF
3.02 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1709657
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact